The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Retrospective analysis of treatment patterns and outcomes with subcutaneous (SQ) bortezomib (BTZ) in patients (pts) with relapsed mantle cell lymphoma (MCL).
Vijayveer Bonthapally
Employment or Leadership Position - Millennium
Stock Ownership - Takeda
Marie-Helene Lafeuille
Research Funding - Millennium
Jonathan Fortier
Research Funding - Millennium
Mei Sheng Duh
Research Funding - Millennium
Yvette Ng
Employment or Leadership Position - Janssen
Stock Ownership - Johnson & Johnson
Helgi Van De Velde
Employment or Leadership Position - Janssen Research & Development
Stock Ownership - Johnson & Johnson
Liviu Niculescu
Employment or Leadership Position - Millennium
Esprit Ma
Employment or Leadership Position - Millennium
Andre Goy
No relevant relationships to disclose